RT Conference Proceedings
T1 THE ANTI-CD20 ANTIBODY RITUXIMAB REDUCES THE INFLAMMATORY AND PROTHROMBOTIC PROFILE OF LEUKOCYTES FROM RHEUMATOID ARTHRITIS PATIENTS AND MODULATES THE ACTIVITY OF ENDOTHELIAL CELLS
A1 Cecchi, I.
A1 Perez-Sanchez, C.
A1 Ruiz-Limon, P.
A1 de la Rosa, I. Arias
A1 Abalos-Aguilera, M. C.
A1 Jimenez-Gomez, Y.
A1 Ortega, R.
A1 Collantes-Estevez, E.
A1 Escudero, A.
A1 Barbarroja, N.
A1 Sciascia, S.
A1 Lopez-Pedrera, C.
PB Bmj publishing group
SN 0003-4967
YR 2017
FD 2017-06-01
LK https://hdl.handle.net/10668/25555
UL https://hdl.handle.net/10668/25555
LA en
DS RISalud
RD Apr 5, 2025